Proteostasis (US-Massachusetts) Drug Class: Small molecule Mechanism/Technology: Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or Proteostasis Network (pathways that maintain a critical balance among protein synthesis, folding, aggregation, trafficking and degradation). Primary Indication: Emphysema, type II diabetes, Alzheimers Disease and Huntington’s Disease Stage: Preclinical
